Elite Pharmaceuticals Inc (ELTP): Operating Cash Flow
$23.75M
Year ended 2026-03-31
$19.04M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $23.75M | +218.5% | 2026-06-29, From 2025-04-01 |
| 2025-03-31 | $7.46M | n/m | 2026-06-29, From 2024-04-01 |
| 2024-03-31 | -$3.24M | n/c | 2025-06-30, From 2023-04-01 |
| 2023-03-31 | $3.34M | -48.7% | 2024-07-01, From 2022-04-01 |
| 2022-03-31 | $6.51M | +103.8% | 2023-06-29, From 2021-04-01 |
| 2021-03-31 | $3.19M | n/m | 2022-06-29, From 2020-04-01 |
| 2020-03-31 | -$1.79M | n/m | 2021-06-14, From 2019-04-01 |
| 2019-03-31 | -$6.79M | n/m | 2020-06-29, From 2018-04-01 |
| 2018-03-31 | -$4.81M | n/m | 2019-06-21, From 2017-04-01 |
| 2017-03-31 | -$7.88M | n/m | 2018-06-14, From 2016-04-01 |
| 2016-03-31 | -$2.77M | n/a | 2018-06-14, From 2015-04-01 |
| No annual figure between 2013-03-31 and 2016-03-31. | |||
| 2013-03-31 | -$1.94M | n/m | 2013-06-21, From 2012-04-01 |
| 2012-03-31 | -$394.1K | n/m | 2013-06-21, From 2011-04-01 |
| 2011-03-31 | $1.55M | n/a | 2012-06-29, From 2010-04-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $23.75M | +218.5% |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$81.04M | n/m |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$75.37M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$27.59M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$35.69M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$206.0K | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$322.98M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$166.78M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | -$8.58M | n/m |
Compare ELTP, MGNX, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗